FTC Sues to Block Acquisition of Exclusive Drug License

The deal would give the French company a pharmaceutical monopoly over Pompe Disease therapy. The Federal Trade Commission (FTC) has taken action to prevent Sanofi from acquiring an…

Read More

FDA Approves Tyruko for Multiple Sclerosis and Crohn’s Disease Treatment

Medication offers options to those who have relapsing forms of the disease. The U.S. Food and Drug Administration (FDA) has authorized Tyruko (natalizumab-sztn), the first biosimilar to Tysabri…

Read More

Back to top